Manufacturing costs are rising rapidly, with no end in sight. Leaders that balance the various tradeoffs can remain competitive over the long run.
![wim-celen-438x438-tcm9-251439.jpg](https://web-assets.bcg.com/dims4/default/3ecfb23/2147483647/strip/true/crop/438x438+0+0/resize/500x500!/format/webp/quality/90/?url=http%3A%2F%2Fboston-consulting-group-brightspot.s3.amazonaws.com%2F44%2Ffb%2Faee961ca44080ec96616da28b332%2Fwim-celen-438x438-tcm9-251439.jpg)
Education
- MBA, University of Chicago
- MSc, financial economics, Katholieke Universiteit Leuven
Wim Celen is a core member of Boston Consulting Group’s Health Care and Operations practices. Since joining the firm in 2005, Wim has worked with clients in the pharmaceutical industry in manufacturing and supply chain as well as corporate development (M&A, joint ventures, and carve-outs). Wim is the global node for pharmaceutical operations benchmarking.
Wim has worked extensively in both Europe and the US. He speaks Dutch, English, French, and Spanish.